No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9688371 |
chr6:2355313-2355314 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs386696125 |
chr6:2355318-2355319 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs34906568 |
chr6:2355320-2355321 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs59292431 |
chr6:2355322-2355323 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs58112041 |
chr6:2355338-2355339 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs140485138 |
chr6:2355339-2355340 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs376867502 |
chr6:2355353-2355354 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs572497172 |
chr6:2355370-2355371 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs2505676 |
chr6:2355375-2355376 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
10 |
rs557902901 |
chr6:2355376-2355377 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs76661626 |
chr6:2355396-2355397 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs201112374 |
chr6:2355428-2355429 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs555797854 |
chr6:2355434-2355435 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs566121938 |
chr6:2355450-2355451 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs535028847 |
chr6:2355452-2355453 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs562406824 |
chr6:2355522-2355523 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs186866585 |
chr6:2355527-2355528 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs73342792 |
chr6:2355535-2355536 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs557166638 |
chr6:2355584-2355585 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs144540201 |
chr6:2355613-2355614 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs539539964 |
chr6:2355649-2355650 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs558913701 |
chr6:2355656-2355657 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs371163683 |
chr6:2355661-2355662 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs561916919 |
chr6:2355664-2355665 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs2505675 |
chr6:2355675-2355676 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundancedisease
|
26 |
rs544991453 |
chr6:2355692-2355693 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs532614970 |
chr6:2355727-2355728 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs564797141 |
chr6:2355743-2355744 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs2479011 |
chr6:2355749-2355750 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs74653118 |
chr6:2355788-2355789 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs2505674 |
chr6:2355806-2355807 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|